Michio Onizawa

1.7k total citations
29 papers, 1.2k citations indexed

About

Michio Onizawa is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Michio Onizawa has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Michio Onizawa's work include NF-κB Signaling Pathways (7 papers), Immune Response and Inflammation (4 papers) and interferon and immune responses (3 papers). Michio Onizawa is often cited by papers focused on NF-κB Signaling Pathways (7 papers), Immune Response and Inflammation (4 papers) and interferon and immune responses (3 papers). Michio Onizawa collaborates with scholars based in Japan, United States and Austria. Michio Onizawa's co-authors include Barbara A. Malynn, Averil Ma, Rommel Advincula, Bao Duong, Alma L. Burlingame, Juan A. Osés-Prieto, Haopeng Wang, Michael T. McManus, Lai Wei and Arthur Weiss and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Michio Onizawa

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michio Onizawa Japan 11 691 551 381 150 145 29 1.2k
Limin Li China 18 689 1.0× 388 0.7× 448 1.2× 80 0.5× 134 0.9× 32 1.2k
Christina Eftychi Greece 8 765 1.1× 381 0.7× 213 0.6× 140 0.9× 157 1.1× 9 1.0k
Alfredo Caro‐Maldonado United States 13 595 0.9× 425 0.8× 279 0.7× 151 1.0× 114 0.8× 14 1.2k
Kelly Verhelst Belgium 12 582 0.8× 594 1.1× 488 1.3× 59 0.4× 183 1.3× 13 1.1k
Mike Hupe Germany 10 1.0k 1.5× 562 1.0× 247 0.6× 54 0.4× 171 1.2× 10 1.3k
Martin Ehrenschwender Germany 18 621 0.9× 415 0.8× 213 0.6× 41 0.3× 152 1.0× 32 1.0k
Kai‐Li He China 9 448 0.6× 629 1.1× 258 0.7× 62 0.4× 179 1.2× 11 1.1k
Christina Doxaki Greece 7 653 0.9× 698 1.3× 484 1.3× 48 0.3× 67 0.5× 8 1.3k
David Saliba United Kingdom 14 375 0.5× 562 1.0× 179 0.5× 49 0.3× 171 1.2× 19 970

Countries citing papers authored by Michio Onizawa

Since Specialization
Citations

This map shows the geographic impact of Michio Onizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michio Onizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michio Onizawa more than expected).

Fields of papers citing papers by Michio Onizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michio Onizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michio Onizawa. The network helps show where Michio Onizawa may publish in the future.

Co-authorship network of co-authors of Michio Onizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Michio Onizawa. A scholar is included among the top collaborators of Michio Onizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michio Onizawa. Michio Onizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wada, Jun, et al.. (2024). Ulcerative Colitis with Acute Pericarditis after Dose Escalation of Mesalazine. Internal Medicine. 64(14). 2165–2169.
2.
Onizawa, Michio, et al.. (2024). N-glycosylation negatively regulates the expression of tumor necrosis factor (TNF) in mouse macrophage. Biochemical and Biophysical Research Communications. 737. 150897–150897.
3.
Matsumoto, Haruki, Yuya Fujita, Michio Onizawa, et al.. (2024). Inhibition of CEACAM1 expression in cytokine-activated neutrophils using JAK inhibitors. BMC Immunology. 25(1). 63–63. 2 indexed citations
4.
Suzuki, Masahiro, Michio Onizawa, Yasuhiro Nemoto, et al.. (2023). Apelin expression is downregulated in T cells in a murine model of chronic colitis. Biochemical and Biophysical Research Communications. 647. 72–79. 3 indexed citations
5.
Hikichi, Takuto, Michio Onizawa, Reiko Kobayashi, et al.. (2022). Colonic Endoscopic Submucosal Dissection for a Granular Cell Tumor with Insufficient Endoscopic Manipulation in the Hepatic Flexure. Case Reports in Gastroenterology. 16(1). 216–222. 1 indexed citations
6.
7.
Onizawa, Michio, Shun‐ichiro Asahara, Yoshiaki Kido, et al.. (2021). Oral administration of d-serine prevents the onset and progression of colitis in mice. Journal of Gastroenterology. 56(8). 732–745. 18 indexed citations
8.
Onizawa, Michio, et al.. (2021). <i>Trichuris trichiura</i> Incidentally Detected by Colonoscopy and Identified by a Genetic Analysis. Internal Medicine. 61(6). 821–825. 1 indexed citations
9.
Tamura, Akiko, Hiroki Matsuda, Yuriko Sakamaki, et al.. (2021). Nickel ions attenuate autophagy flux and induce transglutaminase 2 (TG2) mediated post-translational modification of SQSTM1/p62. Biochemical and Biophysical Research Communications. 542. 17–23. 4 indexed citations
10.
Maeyashiki, Chiaki, Yoichi Nibe, Akiko Tamura, et al.. (2020). Receptor‐Interacting Protein Kinase 3 (RIPK3) inhibits autophagic flux during necroptosis in intestinal epithelial cells. FEBS Letters. 594(10). 1586–1595. 10 indexed citations
11.
Katakura, Kyoko, et al.. (2020). Upregulation of complement C1q reflects mucosal regeneration in a mouse model of colitis. Medical Molecular Morphology. 54(2). 87–94. 4 indexed citations
12.
Kattah, Michael G., Ling Shao, Hiromichi Shimizu, et al.. (2018). A20 and ABIN-1 synergistically preserve intestinal epithelial cell survival. The Journal of Experimental Medicine. 215(7). 1839–1852. 43 indexed citations
13.
Nagaishi, Takashi, Michio Onizawa, Yasuhiro Nemoto, et al.. (2018). B cell activation in the cecal patches during the development of an experimental colitis model. Biochemical and Biophysical Research Communications. 496(2). 367–373. 7 indexed citations
14.
Onizawa, Michio, Shigeru Oshima, Ulf Schulze‐Topphoff, et al.. (2015). The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nature Immunology. 16(6). 618–627. 229 indexed citations
15.
Duong, Bao, Michio Onizawa, Juan A. Osés-Prieto, et al.. (2015). A20 Restricts Ubiquitination of Pro-Interleukin-1β Protein Complexes and Suppresses NLRP3 Inflammasome Activity. Immunity. 42(1). 55–67. 221 indexed citations
16.
Wang, Haopeng, et al.. (2014). Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nature Immunology. 15(4). 393–401. 206 indexed citations
17.
Nagaishi, Takashi, Motomi Yamazaki, Michio Onizawa, et al.. (2014). Myosin Light Chain Kinase Expression Induced via Tumor Necrosis Factor Receptor 2 Signaling in the Epithelial Cells Regulates the Development of Colitis-Associated Carcinogenesis. PLoS ONE. 9(2). e88369–e88369. 44 indexed citations
18.
Mar, Jordan S., Nabeetha Nagalingam, Yuanlin Song, et al.. (2014). Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition.. Gut Microbes. 5(4). 494–503. 45 indexed citations
19.
Lu, Timothy T., Michio Onizawa, Gianna Hammer, et al.. (2013). Dimerization and Ubiquitin Mediated Recruitment of A20, a Complex Deubiquitinating Enzyme. Immunity. 38(5). 896–905. 117 indexed citations
20.
Nagaishi, Takashi, Teruji Totsuka, Michio Onizawa, et al.. (2012). The Development of Colitogenic CD4+ T Cells Is Regulated by IL-7 in Collaboration with NK Cell Function in a Murine Model of Colitis. The Journal of Immunology. 188(6). 2524–2536. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Limin Li Breakdown of academic impact, for papers by Christina Eftychi Breakdown of academic impact, for papers by Alfredo Caro‐Maldonado Breakdown of academic impact, for papers by Kelly Verhelst Breakdown of academic impact, for papers by Mike Hupe Breakdown of academic impact, for papers by Martin Ehrenschwender Breakdown of academic impact, for papers by Kai‐Li He Breakdown of academic impact, for papers by Christina Doxaki Breakdown of academic impact, for papers by David Saliba
Rankless by CCL
2026